发明名称 |
Treatment for nicotine-induced lung disease using peroxisome proliferator-activated receptor gamma agonists |
摘要 |
This invention provides pertains to the discovery that that nicotine interrupts molecular signaling between endodermal and mesodermal cells of the lung alveolus. Treatment of the lung with specific molecular agents (e.g., PPAR gamma agonists) can prevent and/or reverse the injury caused by nicotine. |
申请公布号 |
US9173875(B2) |
申请公布日期 |
2015.11.03 |
申请号 |
US200712296656 |
申请日期 |
2007.04.10 |
申请人 |
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center |
发明人 |
Rehan Virender K.;Torday John S. |
分类号 |
A61K31/44;A61K31/4439 |
主分类号 |
A61K31/44 |
代理机构 |
Weaver Austin Villeneuve & Sampson LLP |
代理人 |
Hunter Tom;Weaver Austin Villeneuve & Sampson LLP |
主权项 |
1. A method of reducing, eliminating, and/or reversing pulmonary tissue damage characterized by smoke-induced pulmonary alveolar trans-differentiation of lipofibroblasts to myofibroblasts in utero in a developing fetus carried by a pregnant mammal, said method comprising administering a PPAR gamma (PPARγ) agonist to said pregnant mammal in an amount sufficient to reduce, eliminate, or reverse said transdifferentiation. |
地址 |
Torrance CA US |